AKR1B10 and neoplasm: Enzyme linked immunosorbent assay (ELISA), Time-resolved fluoroimmunoassay (TRFIA), Reverse transcription polymerase chain reaction (PT-PCR) and Immunohistochemistry was used to determine the expression level of AKR1B10 in serum and tumor tissue.